|
|
||||||||
1 Arizona Prevention Center and 2 Sarver Heart Center and Department of Surgery, University of Arizona, Tucson, Arizona 85724
| |
ABSTRACT |
|---|
|
|
|---|
Our study
compared left ventricular (LV) function between senescent and young
adult mice through in situ pressure-volume loop analysis. Two groups of
mice (n = 9 each), 6-mo-old and
16-mo-old (senescent) mice, were anesthetized with urethan and
-chloralose, and their LV were instrumented with a Millar 1.4-Fr
conductance micromanometer catheter for the acquisition of the
pressure-volume loops. The senescent mice had a significantly decreased
contractile function related to load-dependent parameters, including
stroke volume index, ejection fraction, cardiac output index, stroke work index, and maximum derivative of change in systolic pressure over
time. The load-independent parameters, preload recruitable stroke work
and the slope (end-systolic volume elastance) of the end-systolic
pressure-volume relationship, were significantly decreased in the
senescent mice. Heart rate and arterial elastance were not different
between the two groups; however, the ventricular-to-vascular coupling
ratio (ratio of elastance of artery to end-systolic volume elastance)
was increased by threefold in the senescent mice
(P < 0.001). Thus there
were significant decreases in contractile function in the senescent
mouse heart that appeared to be related to reduced mechanical
efficiency but not related to arterial elastance.
senescence; conductance catheter; end-systolic pressure-volume relationship; preload recruitable stroke work
| |
INTRODUCTION |
|---|
|
|
|---|
ELUCIDATING THE BASIC mechanisms of senescent heart
dysfunction has become increasingly important due to the increased
aging population and the increased incidence of age-related heart
failure. There are numerous reports relating age to functional (41), biochemical, and electrical performance alterations of the isolated heart, using papillary muscle preparations and in human studies (29,
48). Cardiac senescence has been described to be
associated with a cardiac isomyosin shift from
- to
-myosin heavy
chain (50) and with expression of fibrosis-related genes (1).
Alterations of growth controlling factors have been described as
potential mechanisms for senescent dysfunction through expression of
the serum response element gene and induction of
c-fos (37), reduced endocrine factor
and nerve growth factor (46), response to insulin (28), and increased
expression of ANG II receptors (8, 18). Numerous reports have
characterized impairment of excitation-contraction coupling (26, 30)
and calcium homeostasis (2, 48). There are also engaging reports
relating to cardiac senescent changes in nitric oxide synthase
expression (25) and increased rate of myocyte apoptosis (22, 34). In
summary, a unifying mechanism accounting for cardiac senescence remains
to be described. Discovery of the mechanism(s) is complicated by
functional measurements of ventricular mechanics in the aging
subsequent to prolonged hypertension and pathological conditions such
as coronary artery disease. For the above reasons, we set forth to
compare the in situ ventricular mechanical properties of healthy young
and senescent murine hearts.
Much of the reported research related to senescent heart function has been in humans or in rat models (2, 6, 9, 41). However, the use of a mouse model appears to be justified because of the ability to genetically engineer this species. Furthermore, in immunologically mediated myocardiopathy models, the mouse has many advantages because the murine immune response can be precisely defined. Together, use of the murine model appears to be justified when examining left ventricular (LV) dysfunction related to aging or acquired myocardopathies. No reports have been published regarding senescent murine heart function. Furthermore, because the murine cardiovascular system is similar to that of humans (12, 14), the murine model provides a valid way to define age-related alterations in ventricular mechanics and the associated molecular mechanisms. However, the size of the mouse limits the analytical tools available for measurement of LV function in vivo. The conductance-micromanometer system can provide quantification of LV systolic and diastolic performance in the mouse under both load-dependent and load-independent conditions (12). Thus we applied the conductance-micromanometer system to quantify the LV pressure-volume relationships of the young adult heart and the senescent murine heart.
The purpose of this study was to compare the LV functions in young adult and senescent mice. The parameters used for comparison were those that distinguished between load-dependent and load-independent functions. We found that there was a significant decrease in LV contractile function in the senescent mouse heart that was independent of load.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals
All animal studies were performed after approval by our animal review committee. Guidelines for the Care and Use of Laboratory Animals [DHEW Publication No. (NIH) 85-23, Revised 1985, Office of Science and Health Reports, DRR/NIH, Bethesda, MD 20205] and Principles of Laboratory Animal Care (published by the National Society for Medical Research) were followed in this study. Before the study, the mice were conditioned for 1 wk in the animal facility.Eighteen C57BL/6 female mice purchased from Charles River Laboratories
(Wilmington, DE) were divided into two equal groups: group 1, consisting of 6-mo-old mice
(young adult), and group 2, consisting
of 16-mo-old mice (senescent). C57BL/6 female mice were used due to
their common application in immunologic and genetic engineering
studies. The mice were anesthetized with urethan (1,000 mg/kg ip) and
-chloralose (50 mg/kg ip). Respiration was controlled through a
tracheostomy cannula connected to a pressure-controlled respirator (RSP
1002, Kent, CT) with a rate of 120 times/min, and
FIO2 of 1.0. The external
jugular vein was cannulated for volume administration, which was
limited to 200 µl of hetastarch. A substernal transverse incision was
made to expose the apical portion of the heart and the inferior vena
cava (IVC). Electrical cautery was used to ensure minimal blood loss.
The Millar conductance catheter (1.4 Fr) was inserted through a
25-gauge apical stab wound into the LV, and the pericardium was left as
intact as possible. The catheter was positioned along the cardiac
longitudinal axis with the distal electrode in the aortic root and the
proximal electrode in the LV apex.
Conductance Catheter System
The Millar 1.4 Fr catheter (SPR-719) is a composite of four conductance electrodes and a micromanometer. The distance between the conductance sensor electrodes is 4.5 mm, which is equal to the distance between the apex and the aortic valve of the mouse heart. The Millar conductance system controller (Millar MCS-100) was set with the frequency at 20 kHz, the low-pass cutoff frequency at 50 Hz, the full scale current selected at 30 µA, and the pressure transducer (TCB-600) at 1 V/100 mmHg. The signals of the conductance and pressure were digitized by BioBench software (National Instruments, Austin, TX).All steady-state and caval occlusion pressure-volume loops were acquired with the computer data acquisition system while the ventilation was momentarily turned off. To acutely change the cardiac preload, caval occlusion was produced over a 3-s period using a nonmetallic occluder applied to the IVC. The data were recorded as a series of pressure-volume loops (10-20 loops).
Postmortem Quantification of LV Volume
After completion of the study, the heart was arrested at diastole with hypertonic potassium chloride (1 M). Two methods were used to determine the end-diastolic volume (Ved). The LV was flushed with isotonic saline through the mitral valve until all air was purged, and then the aorta was clamped. The LV was filled with saline to a LV end-diastolic pressure of 5 mmHg and weighted with an analytical balance. After gentle compression and blotting, the empty heart was again weighed. The difference between the weights was regarded as the Ved. A second volumetric measurement was made with a casting mixture of resin and catalyst (Biopolymerization Products, Tucson, AZ) at a ratio of 1:0.5. This material was injected into the LV, in a manner similar to the saline method to achieve a LV end-diastolic pressure of 5 mmHg to make a polymer cast of the LV chamber. The heart was suspended by the aorta in a humidified chamber for 48 h to permit complete polymer curing. The LV polymer volume, which was also regarded as the Ved of the LV, was calculated by the mass of the cast divided by the polymer density.Conductance Catheter Calibration for Volume
The most critical element in the application of this conductance system was the volume calibration. We applied two methods to achieve this: calibration with a volume calibration line (VCL) and parallel volume (Vp) and calibration with the experimental slope coefficient (
) and
Vp.
Calibration with VCL and Vp.
The principle of the conductance catheter system (CCS) is a simple
cylindrical equation: V = (L2/
) · G,
where V is absolute volume, L is the
interelectrode distance,
is conductivity of the blood, and
G is conductance (3, 43). We therefore
calibrated our system with a known volume of fresh heparinized whole
murine blood loaded in a series of seven cylinders to derive the VCL.
· r2 · L.
According to the principle of the conductance system, volume was
directly proportional to the conductance. Therefore, regression of the
volume vs. the conductance was linear. Regression of the calculated
volume vs. the corresponding conductance signal produced the regression
line shown in Fig. 1. We used this
volume-conductance regression line as the VCL and the regression
formula as the volume calibration formula (VCF), which was V = 22.103 · G + 6.6;
r2 = 0.995, P < 0.001 (Fig. 1). All
the raw signals of conductance acquired by the conductance catheter
were put into this formula (VCF) to calculate the raw volume
(Vcc). The
Vcc acquired from the mice was
25-55 µl and in the midrange of the VCL.
|
Vp.
The calibration of Vp required use
of a hypertonic saline dilution method, as described by others (4, 7,
20). In our experiments, 10 µl of hypertonic saline (15%) were
injected into the external jugular vein. Passage of the hypertonic
saline through the LV causes the conductance waveform to expand
proportionally to the volume and the conductivity of the blood in LV.
The difference between the end-systolic conductance
(Ges) and the
end-diastolic conductance
(Ged) increased
by about twofold after hypertonic saline injection. A regression line
was constructed for the series Ges vs.
Ged. The
intersection between this regression and the identity line
(y = x) was
defined as the
Gp. The
Vp was calculated from the
Gp with the VCF
(Vp = 22.103 · Gp + 6.6).
In summary, after applying the VCF to calculate
Vcc from the raw signal
conductance and Vp from
Gp, we computed
the instantaneous LV blood volume as shown by V(t) = Vcc
Vp.
Calibration of
.
The principle of the CCS is
|
is the conductivity of the blood,
and
is the experimental slope coefficient for the relationship
between V(t) and G(t)
(24). G(t) is the instantaneous raw conductance signal.
The volume calibration of
was performed by the ratio of the raw
stroke volume (SVcc) measured by
the CCS divided by the stroke volume (SV) measured by a descending
aortic flow probe (Transonics, Ithaca, NY) according to the formula
= SVcc/SV (12, 24). The descending
aortic flow probe measurements in the mouse are 74% of the total
stroke volume (M. Feldman, Department of Cardiology, University of
Texas, San Antonio, TX, personal communication); therefore, all
reported SV measurements were fractionally corrected to account for
aortic arch blood flow.
The calibration of VCL and Vp was
confirmed by the comparison of
SVcc with SV from the flow probe
and of the Ved measured by CCS
with the Ved measured by saline
displacement and LV polymer casting.
Analysis of the Signals
Pvan software (Conductance Technologies, San Antonio, TX, and Millar, Houston, TX) was used to analyze all pressure-volume loop data. Regression analyses of multiple isochronal pressure-volume loop data were produced by IVC compression. From the baseline and IVC compression loops, comprehensive sets of hemodynamic parameters (defined in Table 1) were calculated as shown in Table 2. Only the loops with end-systolic pressures (Pes) >60 mmHg were chosen for analysis by IVC blocking. The parameters of contractility and stiffness of the LV were calculated, including end-systolic volume elastance (Ees), end-systolic pressure-volume relationship (ESPVR), preload recruitable stroke work (PRSW), the slope of end-diastolic pressure-volume relationship (EDPVR), and EDPVR. The ventricular-to-vascular coupling ratio was assessed by the arterial elastance-to-Ees ratio (Ea/Ees). These computations were performed according to those recently reported by Georgakopoulos et al. (12) and previously by others (13, 27, 49).
|
|
Statistical Analysis
All data are reported as means ± SE. The standard volume line was analyzed by simple linear regression. When appropriate, differences between young mice and senescent mice were compared by an unpaired Student's t-test or one-way ANOVA. P < 0.05 was used as criteria for statistical significance.| |
RESULTS |
|---|
|
|
|---|
Hemodynamics of Young and Senescent Mice
Table 2 contrasts the hemodynamic function parameters of young adult to those of senescent mice. We found that the senescent mice had a significantly decreased contractile function compared with the young mice; parameters included stroke index (SI), cardiac index (CI), ejection fraction (EF), stroke work index (SWI), end-systolic pressure (Pes), and maximum derivative of change in systolic pressure over time (dP/dtmax) (P < 0.05). The diastolic function and minimum dP/dt were also significantly less in old mice (P < 0.01); however, there was no significant difference in the time constant of isovolumic relaxation (
) and the slope of EDPVR between
the young and the senescent mice.
LV Contractility
Two typical pressure-volume loop sets generated by IVC compression are shown in Fig. 2. The ESPVR of the senescent mice demonstrated a markedly decreased slope in comparison to that of the young mice. More specifically, the Ees of the senescent mice decreased by threefold (12.02 ± 1.4 mmHg/µl) compared with that of the young mice (42.8 ± 7.6 mmHg/µl) (P < 0.01). PRSW computed by regression of stroke work (SW) to the Ved (r2 = 0.99, P < 0.001) is the slope of the regression line and is shown in Fig. 3. Consistent with the ESPVR data, Table 2 shows that there was about a 28% decrease in the PRSW relationship in the senescent mice (58.8 ± 4.4 mmHg) compared with young mice (83.6 ± 5.7 mmHg) (P < 0.01).
|
|
Efficiency of LV Work
The LV efficiency [ratio of external work to pressure-volume (EW/PVA)] and SWI of young mice were significantly greater than those of the senescent mice (P < 0.05). The Ea was not different between the two age groups; however, the ratio of arterial elastance to ventricular elastance (Ea/Ees) was increased by threefold in the senescent compared with the adult young mice (P < 0.01) (Table 2).Calibration of Volume
When the conductances of the surrounding tissues in the two groups were compared, there was no significant difference between the senescent mice (0.82 ± 0.07 V
1)
and the young mice (0.78 ± 0.09 V
1).
After the calibration with VCF and
Vp, the ventricular
Ved was 15.04 ± 0.86 µl for
the adult young mice and 15.35 ± 1.10 µl for the senescent mice.
Furthermore, the direct volumetric
Ved measurements from the saline
displacement and the polymer cast model were 15.5 ± 0.55 µl and
15.07 ± 0.95 µl, respectively. There were no significant
differences among the Ved results
measured by these three methods (P = 0.936) (Table 3). The SV of the young mice
measured by the CCS (9.99 ± 0.24 µl) was found to be equivalent to the SV measured by the aortic flow probe (9.96 ± 0.97 µl;
P = 0.96) (Table 3). In summary, an
of 1.003 was used for volume computations based on the Doppler flow
measurements and validated by the volumetric determinations.
|
| |
DISCUSSION |
|---|
|
|
|---|
Senescent Heart Function
Our study defined significant in vivo functional differences between the senescent mouse heart compared with the young adult heart. In agreement with other studies reporting other species, we found that the contractile state of the murine senescent heart was significantly decreased. Our study incorporated multiple measurements that were both load dependent and load independent. Load-independent measurements of ventricular contractile state consistently demonstrated decreased function in the senescent mice; however, the diastolic function was slightly different between the two groups. These findings suggest that the senescent contractile dysfunction is related to innate cardiac factors other than response to peripheral vascular resistances, since the Ea was not different between the age groups. Furthermore, the energetic indexes of the senescent mouse heart were shown to be much less efficient than the younger adult heart. In summary, the load-independent parameters PRSW and ESPVR demonstrated an age-related decrease in contractile function of the LV.Comparative Hemodynamics
The LV functional parameters of the young mice were consistent with those reported by others (12, 14, 35, 36). These reports have described similar changes in aging rats (23 mo old), including decreased dP/dtmax, CI, and peak pressure of LV (9, 41). Furthermore, these reports also suggest that the LV diastolic function was minimally different between the two rat age groups (41), which is comparable with our results. In summary, we report that the murine senescent LV contractile function was significantly less than that in the younger adult, which is consistent with results reported in other species.Ees and ESPVR
Ees was computed from the slope of the ESPVR, as illustrated in Fig. 2, A and B. Within a physiologically normal range of LV pressures, Ees is relatively independent of preload and afterload and is a reliable index of LV contractility (27, 42, 47). Our data show that the Ees of old mice was significantly decreased (by threefold) compared with that of young mice, implying that the LV contractility of the senescent mice was significantly less than that of the young. In summary, the decreased Ees in the senescent mice is consistent with the decrease of other LV systolic functions, such as EF, SI, Pes, and dP/dtmax.PRSW
The attributes favoring the use of the PRSW relationship are as follows: 1) the PRSW is a modification of Frank-Starling law, 2) PRSW is less influenced by noise or ventricular geometry, and 3) PRSW is linear. PRSW is also preload independent and afterload insensitive over the physiological range (13, 33). Because of this feature, PRSW is more statistically robust than Ees (23). From our analysis, the derivation of PRSW, as the SW was plotted with Ved, yielded an r2 of 0.99, P < 0.001 (Fig. 3). The last important point is that PRSW is independent of the calibration of
and Vp (see
APPENDIX). This is a very important
issue related to the application of the conductance catheter in the
murine model. The methods for determination of the calibration factor
are not as precise in the mouse as in larger species. Consequently,
the PRSW is an excellent means to characterize LV contractile function
because it does not rely on precision of
factors compared with ESPVR.
In normal hearts, including hearts of animals and humans, the PRSW varies from 75 to 90 mmHg (23). Our data were within that range; that is, the PRSW of normal young mice was 83.5 ± 5.7 mmHg, which is also consistent to that reported by Georgakopoulos et al. (12), which was 82.1 ± 5.6 mmHg. The PRSW of senescent mice was much less than that of the normal young mice, which confirms that the LV contractile function of the senescent mice was much less than that of the young mice. Therefore, the conclusions from parameters of preload-dependent hemodynamics are consistent with preload-independent Ees and PRSW.
Ea and Ventricular Ees
Ea directly affects the systolic function of the heart. Ea is equal to the ratio of the end-systolic pressure and the SV and is considered the most reliable index of LV afterload. Our study demonstrated that there was no difference in Ea between the young adult and senescent mice. That is, the peripheral vascular resistance was not different between 6-mo-old and 16-mo-old mice.In contrast to the Ea data, the ventricular-to-vascular coupling ratio (Ea/Ees) was significantly increased in senescent mice compared with the young mice. Theoretically, the maximal stroke work of LV occurs when Ea/Ees = 1 and the optimal cardiac efficiency is maintained when Ea/Ees = 0.5 (23, 33). In normal human hearts, Ea/Ees is ~0.5 (12), and, in patients with depressed LV function, the ratio has been reported to be >1. It is understood that the increase in Ea/Ees from 0.5 is associated with a decrease in mechanical efficiency (23). Therefore, our results demonstrated that the Ea was equal between the groups; however, the LV function of senescent mice had a decreased mechanical efficiency compared with the hearts of young mice. These observations are supported by our measurement of contractile efficiency.
Contractile Efficiency
The PVA is the area circumscribed by ESPVR, EDPVR, and the systolic portion of the pressure-volume loop (Fig. 4). PVA is an index of myocardial O2 consumption and is a powerful tool in evaluating the coupling of LV mechanical performance to energy use (49). The cardiac energy efficiency can be defined by the EW-to-PVA ratio (Fig. 4) and represents the amount of energy that can be transformed into external work. Our results demonstrated a significant difference (P < 0.009) between young and senescent mice related to the efficiency of the EW-to-PVA ratio. The young mouse hearts transformed 90.6% of the total energy into external work, whereas the senescent LV transformed 75.9% of total energy into external work. In summary, the decrease in cardiac efficiency (EW/PVA) is consistent with the increase in Ea/Ees without changes in the systemic Ea of the senescent mice.
|
Mechanisms of Cardiac Senescence
There are two potential mechanisms of senescent cardiac dysfunction. Cardiac senescence has been characterized by functional lowering of myocardial strength and contraction speed, prolongation of the relaxation phase, and stiffening of the muscle cells, mural connective tissue, and heart valves (6, 9, 48). The integrated calcium influx increases markedly but the rate of uptake of cytoplasmic calcium decreases with each heart beat in the senescent heart (2, 6, 52). This could be a compensatory mechanism to the senescent contractile dysfunction (2, 52) and could account for the reported decreased magnitude of maximal velocity of relaxation (6, 48). However, our data are not consistent with a calcium mechanism due to a lack of differences of the measured
values between the two age groups.
However, in senescent mice, the serum concentrations of interleukin
(IL)-4, IL-6, tumor necrosis factor-
, interferon-
, and IL-1
are increased compared with young mice (21, 31, 32). These
proinflammatory cytokines can induce myocytes to express inducible
nitric oxide synthase (iNOS) (5, 19, 45), which is not normally
expressed in this tissue (39). We have compared the young with
senescent LV using immunohistochemistry and demonstrated significantly
enhanced expression of iNOS in the senescent tissues (data not shown).
This observation is consistent with that reported in other
myocardiopathies (10, 17). Therefore, a second possible mechanism of
senescent LV dysfunction may be mediated through high concentrations of
NO that cause a negative inotropic effect through the cGMP pathway (15,
16, 38, 45) and depressed cardiac efficiency through the peroxynitrite
pathway (40, 44). In summary, a coupling between immune dysregulation
related to the aging process and cardiac dysfunction provides a
possible means of explaining our observed results in the senescent mouse.
Study Limitations
There are some limitations to this technique. The single-frequency conductance catheter used by us may underestimate the LV volume (51). Second, the plastic block model may confine the electrical field produced by the source electrodes. Therefore, it does not exactly model the electrical fields formed in mouse thoracic cavity tissues. However, the volumes of the cylinders were constructed to the volumes acquired as raw conductance signals (Vcc) and not the LV volumes [V(t)] specifically. Furthermore, the restriction of the electrical field may have more of an influence on Vp rather than on V(t) due to the geometry of the field.Both load-dependent parameters (EF, SW, SWI, SI, CI, Pes, and dP/dtmax) and load-independent parameters (Ees and PRSW) revealed marked decreases in contractile function of the senescent mouse heart without differences in the Ea compared with the young adult heart. The mechanical efficiency of LV was also significantly decreased with decreased EW/PVA and increased Ea/Ees. These age-related functional differences between the two age groups appeared to be due to innate cardiac factors rather than compensatory responses related to systemic vascular properties.
| |
APPENDIX |
|---|
|
|
|---|
The PRSW relationship is plotted by SW vs.
Ved, and is linear. The slope of
this line is named PRSW (13). Therefore
|
|
If we let P = MEP
EDP, and since SV = Ved
Ves, then
|
|
is the conductivity of the blood,
is an
experimental slope coefficient for
V(t)
G(t) correlationship, and
Vp is a volume signal error due to the conductance of the tissue surrounding LV (24). Thus
|
|
|
|
and Vp. As a
result, PRSW is independent of the calibration of
and
Vp (and its unit is mmHg).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. David Kass and Marc Feldman for collaborative support with the application of the conductance system in this murine study. We thank Julie Beischel for editing assistance with the manuscript. Also, we thank Ryan Kelly and Mary Rose for technical support.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grant HL-59794-01.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: D. F. Larson, Department of Surgery, University of Arizona, Tucson, AZ 85724 (E-mail: dflarson{at}u.arizona.edu).
Received 20 April 1999; accepted in final form 25 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Annoni, G.,
G. Luvara,
B. Arosio,
N. Gagliano,
F. Fiordaliso,
D. Santambrogio,
G. Jeremic,
L. Mircoli,
R. Latini,
C. Vergani,
and
S. Masson.
Age-dependent expression of fibrosis-related genes and collagen deposition in the rat myocardium.
Mech. Ageing Dev.
101:
57-72,
1998[Medline].
2.
Assayag, P.,
D. Charlemagne,
J. de Leiris,
F. Boucher,
P. Valere,
S. Lortet,
B. Swynghedauw,
and
S. Besse.
Senescent heart compared with pressure overload-induced hypertrophy.
Hypertension
29:
15-21,
1997
3.
Baan, J.,
T. T. A. Jong,
P. L. M. Kerkhof,
R. J. Moene,
A. D. Van Dijk,
E. T. Van Der Velde,
and
J. Koops.
Continuouse stoke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter.
Cardiovasc. Res.
15:
328-334,
1981[Medline].
4.
Baan, J.,
E. T. van der Velde,
H. G. de Bruin,
G. J. Smeeka,
J. Koops,
A. D. van Dijk,
D. Temmerman,
J. Senden,
and
B. Buis.
Continuous measurement of left ventricular volume in animals and humans by conductance catheter.
Circulation
70:
812-823,
1984
5.
Balligand, J.,
D. Ungureanu-Longrois,
W. W. Simmons,
D. Pimental,
and
T. Michel.
Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes.
J. Biol. Chem.
269:
27580-27588,
1994
6.
Besse, S.,
P. Assayag,
C. Delcayre,
F. Carre,
S. Cheav,
Y. Lecarpenter,
and
B. Swynghedauw.
Normal and hypertrophied senescent rat heart: mechanical and molecular characteristics.
Am. J. Physiol.
265 (Heart Circ. Physiol. 34):
H183-H190,
1993
7.
Burkhoff, D.,
E. van der Velde,
D. Kass,
J. Baan,
W. L. Maughan,
and
K. Sagawa.
Accuracy of volume measurement by conductance catheter isolated, ejecting canine hearts.
Circulation
72:
440-447,
1985
8.
Burrell, L. M.,
and
C. I. Johnston.
Angiotensin II receptor anatonists; potential in elderly patients with cardiovascular disease.
Drugs Aging
10:
412-434,
1997.
9.
Capasso, J. M.,
A. Malhotra,
R. M. Remily,
J. Scheuer,
and
E. H. Sonnenblick.
Effects of age on mechanical and electrical performance of rat myocardium.
Am. J. Physiol.
245 (Heart Circ. Physiol. 14):
H72-H81,
1983.
10.
Depre, C.,
X. Havaux,
J. Renkine,
J. L. J. Vanoverschelde,
and
W. Wijns.
Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque.
Cardiovasc. Res.
41:
465-472,
1999
12.
Georgakopoulos, D.,
W. A. Mitzner,
C. Chen,
B. J. Byrne,
H. D. Millar,
J. Hare,
and
D. A. Kass.
In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry.
Am. J. Physiol.
274 (Heart Circ. Physiol. 43):
H1416-H1422,
1998
13.
Glower, D. D.,
J. Spratt,
N. D. Snow,
J. S. Kabas,
J. W. Davis,
C. O. Olsen,
G. S. Tyson,
D. C. Sabiston,
and
J. S. Rankin.
Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work.
Circulation
71:
994-1009,
1985
14.
Grupp, I. L.,
A. Subramaniam,
T. E. Hewett,
J. Robbins,
and
G. Grupp.
Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations.
Am. J. Physiol.
265 (Heart Circ. Physiol. 34):
H1401-H1410,
1993
15.
Hare, J. M.,
and
W. S. Colucci.
Role of nitric oxide in the regulation of myocardial function.
Prog. Cardiovasc. Dis.
38:
155-166,
1995[Medline].
16.
Hare, J. M.,
J. F. Keaney, Jr.,
J. Balligand,
J. Loscalzo,
T. W. Smith,
and
W. S. Colucci.
Role of nitric oxide in parasympathetic modulation of
-adrenergic myocardial contractility in normal dogs.
J. Clin. Invest.
95:
360-366,
1995.
17.
Haywood, G. A.,
P. S. Tsao,
H. E. von der Leyen,
M. J. Mann,
P. J. Keeling,
P. T. Trindade,
N. P. Lewis,
C. D. Byrne,
P. R. Rickenbacher,
N. H. Bishopric,
J. P. Cooke,
W. J. McKenna,
and
M. B. Fowle.
Expression of inducible nitric oxide synthase in human heart failure.
Circulation
93:
1087-1094,
1996
18.
Heymes, C. J.,
S. Silvestre,
C. Llorens-Cortes,
B. Chevalier,
F. Marotte,
B. I. Levy,
B. Swynghedauw,
and
J. L. Samuel.
Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes.
Endocrinology
139:
2579-2587,
1998
19.
Ing, D. J.,
J. Zang,
V. J. Dzau,
K. A. Webster,
and
N. H. Bishopric.
Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak and Bcl-x.
Circ. Res.
84:
21-33,
1999
20.
Ito, H.,
M. Takaki,
U. Yamaguchi,
H. Tachibana,
and
H. Suga.
Left ventricular volumetric conductance catheter for rats.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1509-H1514,
1996
21.
Jiang, S.,
J. Lee,
Z. Zhang,
P. Inserra,
D. Solkoff,
and
R. R. Watson.
Dehydroepiandrosterone synergizes with antioxidant supplements for immune restoration in old as well as retrovirus-infected mice.
J. Nutr. Biochem.
9:
362-369,
1998.
22.
Kajstura, J.,
W. Cheng,
R. Sarangarajan,
P. Li,
J. A. Nitahara,
S. Chapnick,
K. Reiss,
G. Olivetti,
and
P. Anversa.
Necrotic and apoptotic myocyte death in the aging heart of Fisher 344 rats.
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H1215-H1228,
1996
23.
Kaas, D. A.
Clinical ventricular pathophysiology: a pressure-volume view.
In: Ventricular Function, edited by DC Warltier. Baltimore, MD: Williams & Williams, 1995, p. 131-151.
24.
Kaas, D., A.,
T. Yamazski,
D. Burkhoff,
W. L. Maughan,
and
K. Sagawa.
Detetmination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique.
Circulation
73:
586-595,
1986
25.
Khadour, F. H.,
R. H. Kao,
S. Park,
P. W. Armstrong,
B. J. Holycross,
and
R. Schulz.
Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H1223-H1230,
1997
26.
Koban, M. U.,
A. F. Moorman,
J. Holtz,
M. H. Yacoub,
and
K. R. Boheler.
Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence.
Cardiovasc. Res.
37:
405-423,
1998
27.
Kuroda, H.,
and
H. Suga.
Cardiac function of an acute ischemic heart failure model produced by microsphere injection into the left coronary artery.
ASAIO J.
41:
855-862,
1995[Medline].
28.
Kurokawa, T.,
N. Ozaki,
and
S. Ishibashi.
Difference between senescence-accelerated prone and resistant mice in response to insulin in the heart.
Mech. Ageing Dev.
102:
25-32,
1998[Medline].
29.
Lakatta, E. G.
Heart and circulation.
In: Biology of Aging, edited by E. L. Schneider,
and J. W. Rowe. New York: Academic, 1990, p. 181-216.
30.
Leblanc, N.,
D. Chartier,
H. Gosselin,
and
J. L. Rouleau.
Age and gender differences in excitation-contraction coupling of the rat ventricle.
J. Physiol. (Lond.)
511:
533-548,
1998
31.
Lee, L.,
S. Jiang,
B. Liang,
and
R. R. Watson.
Antioxidant supplementation in prevention and treatment of immune dysfunction and oxidation induced by murine aids in old mice.
Nutr. Res.
18:
327-340,
1998.
32.
Liang, B.,
Z. Zhang,
P. Inserra,
S. Jiang,
L. Lee,
and
R. R. Watson.
Injection of T-cell receptor peptide reduces immunosenescence in aged C57BL/6 mice.
Immunology
93:
462-468,
1998[Medline].
33.
Little, W. C.,
and
C. P. Cheng.
Left ventricular systolic and diastolic performance.
In: Ventricular Function, edited by D. C. Warltier. Baltimore, MD: Williams & Williams, 1995, p. 111-129.
34.
Liu, L.,
G. Azhar,
W. Gao,
X. Zhang,
and
J.-Y. Wei.
Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences.
Am. J. Physiol.
275 (Regulatory Integrative Comp. Physiol. 44):
R315-R322,
1998
35.
Lorenz, J. N.,
and
E. G. Kranias.
Regulatory effects of phospholamban a cardiac function in intact mice.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H2826-H2831,
1997.
36.
Lorenz, J. N.,
and
J. Robbins.
Measurement of intraventrcular pressure and cardiac performance in the intact closed-chest anesthetized mouse.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H1137-H1146,
1997
37.
Lu, X.-G.,
G. Azhar,
L. Liu,
H. Tsou,
and
J.-Y. Wei.
SRF binding to SRE in the rat heart: influence of age.
J. Gerentol.
53:
B3-B10,
1998.
38.
Mohan, P.,
D. L. Brutsaert,
W. J. Paulus,
and
S. U. Sys.
Myocardial contractile response to nitric oxide and cGMP.
Circulation
93:
1223-1229,
1996
39.
Moncada, S.,
R. M. J. Palmer,
and
E. A. Higgs.
Nitric oxide: physiology, pathophysiology, and pharmacology.
Pharmacol. Rev.
43:
109-142,
1991[Medline].
40.
Panas, D.,
F. H. Khadour,
C. Szabo,
and
R. Schulz.
Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism.
Am. J. Physiol.
275 (Heart Circ. Physiol. 44):
H1016-H1023,
1998
41.
Raya, T. E.,
M. Gaballa,
P. Anderson,
and
S. Goldman.
Left ventricular function and remodeling after myocardial infarction in aging rats.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H2652-H2658,
1997
42.
Sagawa, K.,
L. Maughan,
H. Suga,
and
K. Sunagawa.
Cardiac Contraction and Pressure-Volume Relationship. New York: Oxford, 1988.
43.
Salo, R. W.,
T. G. Wallner,
and
B. D. Pederson.
Measurement of ventricular volume by intracardiac impedance: theoretical and empirical approaches.
IEEE Trans. Biomed. Eng.
33:
189-195,
1986[Medline].
44.
Schulz, R.,
K. L. Dodge,
G. D. Lopaschuk,
and
A. S. Clanachan.
Peroxynitrite impairs cardiac contactile function by decreasing cardiac efficiency.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H1212-H1219,
1997
45.
Stein, B.,
P. Frank,
W. Schmitz,
H. Scholz,
and
M. Thoenes.
Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase.
J. Mol. Cell. Cardiol.
28:
1631-1639,
1996[Medline].
46.
Stuerenburg, H. J.,
and
K. Kunze.
Tissue concentrations of nerve growth factor in aging rat heart and skeletal muscle.
Muscle Nerve
21:
404-406,
1998[Medline].
47.
Suga, H.
Cardiac performance as viewed through the pressure-volume window.
Jpn. Heart J.
35:
263-280,
1994[Medline].
48.
Svanborg, A.
Aged-related changes in cardiac physiology. Can they be postponed or treated by drugs?
Drugs Aging
10:
463-472,
1997[Medline].
49.
Takaoka, H.,
M. Takeuchi,
M. Odake,
and
M. Yokoyama.
Assessment of myocardial oxygen comsumption (VO2) and systolic pressure-volume area (PVA) in human hearts.
Eur. Heart J.
13:
85-90,
1992.
50.
Van der Velden, J.,
A. F. Moorman,
and
G. J. Stienen.
Age-dependent changes in myosin composition with enhanced economy of contraction in guinea-pig heart.
J. Physiol. (Lond.)
507:
497-510,
1998
51.
Wu, C. C.,
T. C. Skalak,
T. R. Schwenk,
C. M. Mahler,
A. Anne,
P. W. Finnerty,
H. L. Haber,
R. M. Weikle,
and
M. D. Feldman.
Accuracy of the conductance catheter for measurement of ventricular volumes seen clinically: effects of electric field homogeneity and parallel conductance.
IEEE Trans. Biomed. Eng.
44:
266-277,
1997[Medline].
52.
Zhou, Y. Y.,
E. G. Lakatta,
and
R. P. Xiao.
Age-associated alterations in calcium current and its modulation in cardiac myocytes.
Drugs Aging
13:
159-171,
1998[Medline].
This article has been cited by other articles:
![]() |
K. M. Shioura, D. L. Geenen, and P. H. Goldspink Sex-related changes in cardiac function following myocardial infarction in mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R528 - R534. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Shioura, D. L. Geenen, and P. H. Goldspink Assessment of cardiac function with the pressure-volume conductance system following myocardial infarction in mice Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2870 - H2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Afilalo, I. A. Sebag, L. E. Chalifour, D. Rivas, R. Akter, K. Sharma, and G. Duque Age-related changes in lamin A/C expression in cardiomyocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1451 - H1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Nielsen, S. B. Kristiansen, S. Ringgaard, T. T. Nielsen, A. Flyvbjerg, A. N. Redington, and H. E. Botker Left ventricular volume measurement in mice by conductance catheter: evaluation and optimization of calibration Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H534 - H540. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Haris Naseem, A. P. Meeson, J. Michael DiMaio, M. D. White, J. Kallhoff, C. Humphries, S. C. Goetsch, L. J. De Windt, M. A. Williams, M. G. Garry, et al. Reparative myocardial mechanisms in adult C57BL/6 and MRL mice following injury Physiol Genomics, June 19, 2007; 30(1): 44 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Joho, S. Ishizaka, R. Sievers, E. Foster, P. C. Simpson, and W. Grossman Left ventricular pressure-volume relationship in conscious mice Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H369 - H377. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Costandi, L. R. Frank, A. D. McCulloch, and J. H. Omens Role of diastolic properties in the transition to failure in a mouse model of the cardiac dilatation Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2971 - H2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Alwardt, Q. Yu, H. L. Brooks, M. R. McReynolds, R. Vazquez, R. R. Watson, and D. F. Larson Comparative effects of dehydroepiandrosterone sulfate on ventricular diastolic function with young and aged female mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R251 - R256. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yu, R. R. Watson, J. J. Marchalonis, and D. F. Larson A role for T lymphocytes in mediating cardiac diastolic function Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H643 - H651. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. G. Mabley, L. Liaudet, O. V. Evgenov, A. Marton, G. Hasko, M. Kollai, and C. Szabo Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2132 - H2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramani, M. Mathier, P. Wang, G. Gibson, S. Togel, J. Dawson, A. Bauer, S. Alber, S. C. Watkins, C. F. McTiernan, et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a mur |